EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review

Sanjana Bhagwat iD, Amol Bapaye iD

DEN Open · 2027-04 · 7 (1)

DOI: 10.1002/deo2.70397 ↗

At a glance

Übersichtsarbeit in DEN Open, published online on 2026-08-12. Written by Sanjana Bhagwat and 1 co-authors. Institution: Shivanand Desai Center for Digestive Disorders Deenanath Mangeshkar Hospital and Research Center Pune India. 59 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders.

Methods

This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from the literature.

Results

Peroral endoscopic myotomy (POEM) for achalasia cardia is now established as first‐line therapy, endorsed by the American Society for Gastrointestinal Endoscopy, American College of Gastroenterology, Society of American Gastrointestinal and Endoscopic Surgeons, and international expert bodies, with long‐term clinical success exceeding 90% at 7 years. Since 2010, the technique has evolved considerably, with refinements in myotomy length, orientation, and depth, along with intraoperative use of an endoluminal functional lumen imaging probe to optimize outcomes and reduce post‐procedure gastroesophageal reflux (GER). The TSE platform has since expanded to spastic esophageal disorders, esophagogastric junction outflow obstruction, Zenker's and epiphrenic diverticula (Z‐POEM/D‐POEM), refractory gastroparesis (gastric per‐oral endoscopic pyloromyotomy), and Hirschsprung's disease. Techniques have also been modified along the way to achieve better results while minimizing AEs. Post‐POEM GER, occurring objectively in 40%–55% of patients, remains the principal long‐term challenge, and multiple modalities have been explored to address it.

Conclusions

TSE has fundamentally transformed the management of benign gastrointestinal motility disorders, with POEM serving as the paradigm for the shift from surgical to endoscopic treatment. Ongoing technical refinement, GER mitigation strategies, and emerging innovations are poised to further advance the field. Trial Registration N/A.

Subjects

Author keywords

G‐POEMPOEMZ‐POEMperoral endoscopic myotomythird‐space endoscopy

Authors and institutions

  • Shivanand Desai Center for Digestive Disorders Deenanath Mangeshkar Hospital and Research Center Pune India.

ORCID profiles: Sanjana Bhagwat, Amol Bapaye

Cite

APA

Bhagwat, S., & Bapaye, A. (2027). Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review. DEN Open, 7(1). https://doi.org/10.1002/deo2.70397

Vancouver

Bhagwat S, Bapaye A. Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review. DEN Open. 2027;7(1). doi:10.1002/deo2.70397

BibTeX
@article{Bhagwat2027,
  author = {Bhagwat, Sanjana and Bapaye, Amol},
  title = {Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review},
  journal = {DEN Open},
  year = {2027},
  volume = {7},
  number = {1},
  doi = {10.1002/deo2.70397}
}
Start for free →